LOGIN  |  REGISTER
Viking Therapeutics
Terns Pharmaceuticals

Anson Funds and Cable Car Capital Issue Statement Regarding MEI Pharma’s Rejection of Their Acquisition Proposal

June 01, 2023 | Last Trade: US$2.92 0.09 -2.99

TORONTO and SAN FRANCISCO, June 01, 2023 (GLOBE NEWSWIRE) -- Anson Funds (“Anson”) and Cable Car Capital LLC (“Cable Car” and, together with Anson, “we” or “us”), which collectively beneficially own approximately 14.8% of the outstanding common stock of MEI Pharma, Inc. (the “Company” or “MEIP”; NasdaqCM: MEIP), today issued the following statement in response to the rejection by the Company’s board of directors (the “Board”) of our proposal to acquire all outstanding shares of MEIP not already held by our respective funds for cash consideration of not less than $8.00 per share, plus a contingent value right representing the right to receive 80% of the net proceeds from any license or disposition of the Company’s clinical assets (the “Acquisition Proposal”):

“We believe the Board’s outright rejection of our Acquisition Proposal, without any effort to engage with us, represents a complete derogation of its fiduciary duties to the Company’s stockholders. It is simply inaccurate for the Board to state that our Acquisition Proposal does not provide a basis for discussions. We believe it is incumbent on the Board to act promptly on our Acquisition Proposal to preserve and protect stockholder value, rather than continue down the path of its highly uncertain transaction with Infinity Pharmaceuticals. We reiterate our willingness to meet with the Board to discuss our Acquisition Proposal in good faith, as we firmly believe that it will result in a far superior outcome for stockholders than the Infinity transaction. Should those discussions reveal additional value inherent in the Company, we would also be willing to consider modifications to our Acquisition Proposal to reflect new information. We urge our fellow stockholders who support our Acquisition Proposal to make their views known and have their voices heard by the Board.”

About Anson

Anson Funds is a privately held alternative asset manager with $1.6B in assets. The firm was founded in 2007 with offices in Toronto and Dallas.

About Cable Car

Cable Car Capital LLC is a registered investment adviser based in San Francisco and the general partner of Funicular Funds, LP, an investment partnership.

Media and Investor Contacts

Anson Funds
Taheer Datoo
Portfolio Manager
(416) 447-8874
This email address is being protected from spambots. You need JavaScript enabled to view it. 

Cable Car Capital LLC
Steve Zelinger
General Counsel
(650) 438-3434
This email address is being protected from spambots. You need JavaScript enabled to view it. 


Chimerix

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB